TOX3 is expressed in mammary ER+ epithelial cells and regulates ER target genes in luminal breast cancer

被引：0
|
作者：
Akop Seksenyan
Asha Kadavallore
Ann E Walts
Brian de la Torre
Dror Berel
Samuel P Strom
Parinaz Aliahmad
Vincent A Funari
Jonathan Kaye
机构：
[1] Cedars-Sinai Medical Center,Research Division of Immunology, Departments of Biomedical Sciences and Medicine
[2] Cedars-Sinai Medical Center,Department of Pathology and Laboratory Medicine
[3] Samuel Oschin Comprehensive Cancer Institute,Center for Applied Molecular Medicine
[4] Cedars-Sinai Medical Center,Genomics Core Facility
[5] University of Southern California,Department of Pathology and Laboratory Medicine
[6] Keck School of Medicine,Department of Medicine, David Geffen School of Medicine
[7] Cedars-Sinai Medical Center,undefined
[8] University of California Los Angeles David Geffen School of Medicine,undefined
[9] University of California,undefined
来源：
BMC Cancer | / 15卷
关键词：
TOX3; Luminal B breast cancer; TFF1; HMG-box factor; ER target gene activation; Mammary epithelial progenitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] An allelic series of rat mutations reveal a role of TOX3 in mammary gland development, obesity, and breast cancer susceptibility.
    Shunkwiler, Lauren B.
    Pipaliya, Royal
    Ashy, Cody C.
    Van Peel, Benjamine
    Zhao, Yang
    Guz, Jan
    Awgulewitsch, Alexander
    Kern, Michael J.
    Smits, Bart M. G.
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 76 - 77
  • [32] Investigation of differentially expressed genes in ER plus PR- invasive breast cancer
    Althobiti, M. M. A.
    Albugami, R. R. A.
    Alnamnakani, M. M. A.
    Alharbi, S. A. A.
    Lashin, A. G.
    JOURNAL OF PATHOLOGY, 2024, 264 : S11 - S12
  • [33] The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer
    Romain Tropée
    Bárbara de la Peña Avalos
    Madeline Gough
    Cameron Snell
    Pascal H. G. Duijf
    Eloïse Dray
    Breast Cancer Research and Treatment, 2021, 185 : 601 - 614
  • [34] IGF-1R signaling in ER+ and triple negative breast cancer - a potential target for therapy?
    De, P.
    Sun, Y.
    Dey, N.
    Leyland-Jones, B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S16 - S16
  • [35] Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes
    Chitra Joseph
    Olivia Macnamara
    Madeleine Craze
    Roslin Russell
    Elena Provenzano
    Christopher C. Nolan
    Maria Diez-Rodriguez
    Sultan N. Sonbul
    Mohammed A. Aleskandarany
    Andrew R. Green
    Emad A. Rakha
    Ian O. Ellis
    Abhik Mukherjee
    British Journal of Cancer, 2018, 118 : 1142 - 1151
  • [36] Bisphenol A Induces Sox2 in ER+ Breast Cancer Stem-Like Cells
    M. Angeles Lillo
    Cydney Nichols
    Tiffany N. Seagroves
    Gustavo A. Miranda-Carboni
    Susan A. Krum
    Hormones and Cancer, 2017, 8 : 90 - 99
  • [37] XBP1 regulates the expression of cell cycle associated genes in ERα positive breast cancer cells
    Barua, David
    Sultana, Afrin
    Islam, Md Nahidul
    Gupta, Ananya
    Gupta, Sanjeev
    CANCER RESEARCH, 2020, 80 (16)
  • [38] Proteasome inhibition represses ERα gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer
    G L Powers
    S J Ellison-Zelski
    A J Casa
    A V Lee
    E T Alarid
    Oncogene, 2010, 29 : 1509 - 1518
  • [39] Chemoprevention with tamoxifen and Avemar® by inducing apoptosis on MCF-7 (ER+) breast cancer cells
    Tompa, A
    Kocsis, Z
    Maresek, Z
    Jakab, M
    Szende, B
    Hidvégi, M
    PROCEEDINGS OF THE 2ND CONGRESS OF THE WORLD SOCIETY FOR BREAST HEALTH, 2003, : 61 - 66
  • [40] Bisphenol A Induces Sox2 in ER+ Breast Cancer Stem-Like Cells
    Lillo, M. Angeles
    Nichols, Cydney
    Seagroves, Tiffany N.
    Miranda-Carboni, Gustavo A.
    Krum, Susan A.
    HORMONES & CANCER, 2017, 8 (02): : 90 - 99
12345